Mylan Begins Voluntary Recall of Several EpiPen Auto-Injectors
Rare cases of ‘failure to activate’ spurred the action, the company says.
Rare cases of ‘failure to activate’ spurred the action, the company says.
According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.
The pharmaceutical company has outlined steps to lower the financial burden of acquiring their products after price hike.